Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. The differences in antibodies suggest…
Read More
Most people mount a strong antibody response to SARS-CoV-2 that does not decline rapidly: study
The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October…
Read More
Study shows similar antibody response to key SARS-CoV-2 ‘spike’ protein in COVID-19
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that antibody responses to SARS-CoV-2 are similar in COVID-19 patients with and without diabetes, and thus are unlikely to be responsible for the…
Read More
Study shows SARS-CoV-2 jumped between people and mink, providing strong evidence of zoonotic transmission
A study investigating SARS-CoV-2 infections across 16 mink farms in the Netherlands, being presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that the virus likely jumped between people and mink and back, providing…
Read More
Study shows high prevalence of fatigue following SARS-CoV-2 infection independent of COVID-19 disease severity
Research being presented at the ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that persistent fatigue occurs in more than half of patients recovered from COVID-19, regardless of the seriousness of their infection. The study is…
Read More
Nigerian scientists have identified seven lineages of SARS-CoV-2: Why it matters
By the first week of August 2020 the COVID-19 pandemic had caused about 654,000 deaths worldwide. In Nigeria, as of July 28, there were 38,945 confirmed cases recorded with 813 deaths. The pandemic hit the African continent last, and the…
Read More
Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible
Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections. The study was conducted…
Read More
Study explains multipronged SARS-CoV-2 attack and widepread COVID-19 infection
A study of a gateway receptor for SARS-CoV-2 led by Walter Lukiw, Ph.D., Professor of Neuroscience, Neurology and Ophthalmology at LSU Health New Orleans’ Neuroscience Center of Excellence and School of Medicine, may help explain the wide variety of symptoms…
Read More
Cloth face masks can reduce the spread of SARS-CoV-2: new study
A literature review coordinated by Karolinska Institutet in Sweden and McMaster University in Canada demonstrates that cloth face masks provide clinically useful levels of filtration, which has the potential to reduce the spread of viruses such as SARS-CoV-2. The findings,…
Read More
Malaria drug chloroquine does not inhibit SARS-CoV-2
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2). In order to obtain an effective therapy for COVID-19 as quickly as possible, drugs that are being…
Read More